Average Co-Inventor Count = 5.84
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Car LLC (29 from 44 patents)
2. Enanta Pharmaceuticals, Inc. (25 from 290 patents)
3. Celgene Avilomics Research, Inc. (25 from 44 patents)
4. Sanofi (7 from 1,451 patents)
5. Avila Therapeutics, Inc. (2 from 5 patents)
6. Bristol-myers Squibb Compnay (1 from 3,681 patents)
7. Emata Pharmaceuticals, Inc (1 from 1 patent)
83 patents:
1. 12473304 - Heterocyclic PAD4 inhibitors
2. 11584757 - MK2 inhibitors and uses thereof
3. 11542492 - Ligand-directed covalent modification of protein
4. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
5. 11096942 - Heterocyclic compounds and uses thereof
6. 11098061 - MK2 inhibitors and uses thereof
7. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
8. 10774052 - Heteroaryl compounds and uses thereof
9. 10662195 - Protein kinase conjugates and inhibitors
10. 10618902 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
11. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
12. 10577380 - MK2 inhibitors and uses thereof
13. 10434101 - Heterocyclic compounds and uses thereof
14. 10253040 - MK2 inhibitors and uses thereof
15. 10189794 - Heteroaryl compounds and uses thereof